news

FY Energy Launches BTC Cloud Computing Contracts Backed by Green Energy as Institutional Demand Surges

New Jersey City, Aug. 30, 2025 (GLOBE NEWSWIRE) -- Amid growing institutional participation and regulatory milestones in the cryptocurrency sector,…

3 months ago

FYEnergy Ramps Up ETH Staking Offers as Ethereum Powers U.S. Blockchain Push & DeFi Soars

New York City, NY, Aug. 30, 2025 (GLOBE NEWSWIRE) -- In response to Ethereum’s historic performance this month, FY Energy is…

3 months ago

Trade Vector AI: How Trade Vector Artificial Intelligence Platform Is Transforming Automated Trading Systems

New York City, NY, Aug. 30, 2025 (GLOBE NEWSWIRE) -- Introduction – What is Trade Vector AI Trade Vector AI…

3 months ago

Mind Over Mont Blanc: ASICS Athlete Tom Evans Wins UTMB 2025, Teammate Ben Dhiman Takes Second

The ASICS Trail Team is taking body and mind to new heights during this year’s UTMB® races, including the incredible…

3 months ago

Bybit x Santiment DeFi Report: Platform Tokens Shine As MNT Sees Over $1M Whale Transactions

DUBAI, UAE, Aug. 30, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has released a DeFi report in…

3 months ago

Wonderful Indonesia Shines at ITB India 2025: From Bali to Beyond

MUMBAI, India , Aug. 30, 2025 /PRNewswire/ -- Indonesia is set to make a strong statement at ITB India 2025, bringing the…

3 months ago

Novartis Leqvio shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain

V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LDL-C)…

3 months ago

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension

Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3In the…

3 months ago

New REDUCE-IT Analyses Presented at ESC 2025 Include Data Showing VASCEPA/VAZKEPA (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups

-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or…

3 months ago

Novacore Innovations Becomes India’s First GPU Cloud to Deploy NVIDIA Blackwell Servers

MUMBAI, India, Aug. 29, 2025 /PRNewswire/ -- Novacore Innovations, headquartered in Mumbai, today announced the deployment of India's first GPU…

3 months ago